GenoFocus Inc Market Cap ($42.40 Million)
Market Cap & Net Worth: GenoFocus Inc (187420)
GenoFocus Inc market cap. GenoFocus Inc (KQ:187420) has a market capitalization of $42.40 Million (₩62.57 Billion) as of November 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22314 globally and #1418 in its home market, demonstrating a -4.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GenoFocus Inc's stock price ₩2130.00 by its total outstanding shares 29375160 (29.38 Million). Also see 187420 cash generation efficiency for how efficiently the company converts equity into cash flow.
GenoFocus Inc Market Cap History (2015–2026)
GenoFocus Inc market cap history from 2015 to 2026. Data shows change from $183.64 Million to $42.40 Million (-14.05% CAGR). Check 187420 stock price and chart for real-time trading data and today's change.
Index Memberships
GenoFocus Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$207.23 Billion | 0.02% | #678 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$207.23 Billion | 0.02% | #678 of 1384 |
Weight: GenoFocus Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GenoFocus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GenoFocus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GenoFocus Inc (187420) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
GenoFocus Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
GenoFocus Inc's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $193.60 Million | $7.03 Billion | $1.61 Billion | 0.03x | 0.12x |
| 2017 | $206.04 Million | $11.51 Billion | $1.41 Billion | 0.02x | 0.15x |
| 2018 | $140.15 Million | $11.52 Billion | -$2.32 Billion | 0.01x | N/A |
| 2019 | $113.47 Million | $14.94 Billion | -$5.76 Billion | 0.01x | N/A |
| 2020 | $218.98 Million | $18.77 Billion | -$12.22 Billion | 0.01x | N/A |
| 2021 | $162.64 Million | $25.87 Billion | -$6.82 Billion | 0.01x | N/A |
| 2022 | $108.49 Million | $27.80 Billion | -$12.97 Billion | 0.00x | N/A |
| 2023 | $77.74 Million | $27.01 Billion | -$2.95 Billion | 0.00x | N/A |
| 2024 | $88.79 Million | $35.43 Billion | -$18.83 Billion | 0.00x | N/A |
| 2025 | $52.75 Million | $43.37 Billion | $22.59 Billion | 0.00x | 0.00x |
Competitor Companies of 187420 by Market Capitalization
Companies near GenoFocus Inc in the global market cap rankings as of November 5, 2026. Also see how large is GenoFocus Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to GenoFocus Inc by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #94 globally with a market cap of $215.12 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #240 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #251 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #291 globally with a market cap of $89.91 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #94 | Linde plc Ordinary Shares | NASDAQ:LIN | $215.12 Billion | $524.74 |
| #240 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #251 | Air Liquide SA | PA:AI | $101.06 Billion | €187.36 |
| #291 | Sherwin-Williams Co | NYSE:SHW | $89.91 Billion | $363.50 |
Market Capitalization of GenoFocus Inc (2015–2026)
Market capitalization of GenoFocus Inc from 2015 to today. Between 2015 and today, GenoFocus Inc's market cap moved from $183.64 Million to $ 42.40 Million, with a yearly change of -14.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩42.40 Million | -19.62% |
| 2025 | ₩52.75 Million | -40.58% |
| 2024 | ₩88.79 Million | +14.21% |
| 2023 | ₩77.74 Million | -28.35% |
| 2022 | ₩108.49 Million | -33.29% |
| 2021 | ₩162.64 Million | -25.73% |
| 2020 | ₩218.98 Million | +92.98% |
| 2019 | ₩113.47 Million | -19.03% |
| 2018 | ₩140.15 Million | -31.98% |
| 2017 | ₩206.04 Million | +6.43% |
| 2016 | ₩193.60 Million | +5.42% |
| 2015 | ₩183.64 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of GenoFocus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.40 Million USD |
| MoneyControl | $42.40 Million USD |
| MarketWatch | $42.40 Million USD |
| marketcap.company | $42.40 Million USD |
| Reuters | $42.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GenoFocus Inc
HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more